Weekly Cannabis News Roundup

Sarah Francey Blog, Weekly Roundup 0 Comments

With so much changing day-to-day with medical cannabis and the looming legalization date in Canada, it can be easy to miss some of the updates. We publish weekly recap blogs of the top stories from the cannabis world, so you can stay in the know.

News cycle for July 9 to 15, 2018:

  • Cannabis for kids? Almost half of Canadian pediatricians didn’t know they could prescribe, survey reveals. 49 per cent of Doctors weren’t even aware they can prescribe cannabis to children, according to a survey of pediatricians released Thursday by the Canadian Paediatric Surveillance Program (CPSP), and 39 per cent didn’t know they could prescribe to youth. More than three-quarters reported little to no knowledge about why cannabis might be used or what the correct dosage might be. This survey is just one step toward untangling the confusion around how pediatricians can and should use medical marijuana.
  • Top 7 Ways Cannabis Can Strengthen National Public Health. An article by The Fresh Toast outlines seven reasons how cannabis can strengthen public health. The reasoning is based on cannabis’ effects on lowering binge drinking rates; reduction of the development of dementia, which when linked to excess drinking is highly preventable; it’s associated to reduced opioid fatalities in areas which it is legalized; effect on diabetes; lower Medicare costs (the article is from the U.S.); and a reduction of domestic violence rates. To learn more about each factor and the associated studies that back them, click here!
  • Legalizing Marijuana Doesn’t Lead To Higher Youth Use, New Study Shows. A primary concern when it comes to legalization, according to prohibition advocates such as Smart Approaches to Marijuana (SAM), is that establishing legal marijuana markets would cause more youth to seek out cannabis. However, a new study found that relatively few differences were observed between states with an established market and those that only recently legalized, which suggests that differences between legal and non-legal states may be partly due to pre-established trends and a type of ‘self-selection’ effect, in that states that legalize non-medical cannabis typically have higher rates of cannabis use anyway.
  • Medical Marijuana Reduces Opioid Prescriptions, Another Study Finds. The study found that statewide medical cannabis legalization implemented in 1993 – 2014 in the US was associated with close to 30% reductions in Schedule III opioids received by Medicaid enrollees. Calculating the cost of opioid pain drugs that patients would have otherwise purchased, the study estimated that medical cannabis legalization in states that have so far adopted it saves the federal government $7.46 million in annual Medicaid spending. Add to that an additional $6.54 million in savings for states.

Leave a Reply

Your email address will not be published. Required fields are marked *